Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05725746 · ClinicalTrials.gov registry record
Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 18
- Enrollment target
NCT05725746 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 18 participants.
The verdict
NCT05725746 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Conduct a pilot study to test feasibility of doing remote data collection with a point of care device that measures HbA1c.
Interventions
- DIAGNOSTIC_TEST Point of care device to measure HbA1c
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-02-24 |
| Est. Completion | 2024-04-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05725746
The ClinicalTrials.gov registry entry for NCT05725746 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Point of care device to measure HbA1c is the first listed.
NCT05725746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05725746 about?
NCT05725746 is a clinical study titled "Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c". Conduct a pilot study to test feasibility of doing remote data collection with a point of care device that measures HbA1c.
What is the current status of trial NCT05725746?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2023-02-24. Estimated completion is 2024-04-25.
What interventions are being tested in trial NCT05725746?
The interventions under investigation include: Point of care device to measure HbA1c (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05725746?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.